WO2009023812A1 - Treatment of nail-bed fungus by application of heat - Google Patents
Treatment of nail-bed fungus by application of heat Download PDFInfo
- Publication number
- WO2009023812A1 WO2009023812A1 PCT/US2008/073258 US2008073258W WO2009023812A1 WO 2009023812 A1 WO2009023812 A1 WO 2009023812A1 US 2008073258 W US2008073258 W US 2008073258W WO 2009023812 A1 WO2009023812 A1 WO 2009023812A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- infection
- thermal
- nail
- nail bed
- treatment
- Prior art date
Links
- 210000004904 fingernail bed Anatomy 0.000 title claims abstract description 25
- 238000011282 treatment Methods 0.000 title claims description 145
- 241000233866 Fungi Species 0.000 title claims description 11
- 206010061303 Nail bed infection Diseases 0.000 claims abstract description 39
- 210000000282 nail Anatomy 0.000 claims description 60
- 238000000034 method Methods 0.000 claims description 41
- 238000012546 transfer Methods 0.000 claims description 36
- 238000010438 heat treatment Methods 0.000 claims description 30
- 241001480043 Arthrodermataceae Species 0.000 claims description 9
- 241000894006 Bacteria Species 0.000 claims description 9
- 230000037304 dermatophytes Effects 0.000 claims description 9
- 208000015181 infectious disease Diseases 0.000 claims description 9
- 230000004044 response Effects 0.000 claims description 8
- 206010017533 Fungal infection Diseases 0.000 claims description 7
- 241000700605 Viruses Species 0.000 claims description 7
- 239000000853 adhesive Substances 0.000 claims description 6
- 230000001070 adhesive effect Effects 0.000 claims description 6
- 229940121375 antifungal agent Drugs 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 208000031888 Mycoses Diseases 0.000 claims description 4
- 239000003429 antifungal agent Substances 0.000 claims description 3
- 208000035143 Bacterial infection Diseases 0.000 claims 3
- 208000007163 Dermatomycoses Diseases 0.000 claims 3
- 208000036142 Viral infection Diseases 0.000 claims 3
- 208000022362 bacterial infectious disease Diseases 0.000 claims 3
- 230000009385 viral infection Effects 0.000 claims 3
- 239000004020 conductor Substances 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- 230000003902 lesion Effects 0.000 description 15
- 208000010195 Onychomycosis Diseases 0.000 description 13
- 201000005882 tinea unguium Diseases 0.000 description 12
- 241000186427 Cutibacterium acnes Species 0.000 description 9
- 230000007704 transition Effects 0.000 description 9
- 238000010586 diagram Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 230000006378 damage Effects 0.000 description 6
- 230000000007 visual effect Effects 0.000 description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000002123 temporal effect Effects 0.000 description 4
- 208000002874 Acne Vulgaris Diseases 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 230000000843 anti-fungal effect Effects 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000003685 thermal hair damage Effects 0.000 description 3
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000009849 deactivation Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 238000005485 electric heating Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000011152 fibreglass Substances 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000012678 infectious agent Substances 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 229960004125 ketoconazole Drugs 0.000 description 2
- 208000026721 nail disease Diseases 0.000 description 2
- 229920002379 silicone rubber Polymers 0.000 description 2
- 239000004945 silicone rubber Substances 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- SODWJACROGQSMM-UHFFFAOYSA-N 5,6,7,8-tetrahydronaphthalen-1-amine Chemical compound C1CCCC2=C1C=CC=C2N SODWJACROGQSMM-UHFFFAOYSA-N 0.000 description 1
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
- 208000020154 Acnes Diseases 0.000 description 1
- 241000884007 Arachnomyces nodosetosus Species 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 238000009631 Broth culture Methods 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 241001480035 Epidermophyton Species 0.000 description 1
- 241000223218 Fusarium Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 241001480037 Microsporum Species 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 206010067152 Oral herpes Diseases 0.000 description 1
- 206010034016 Paronychia Diseases 0.000 description 1
- 241000122799 Scopulariopsis Species 0.000 description 1
- 241000223255 Scytalidium Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- SCKYRAXSEDYPSA-UHFFFAOYSA-N ciclopirox Chemical compound ON1C(=O)C=C(C)C=C1C1CCCCC1 SCKYRAXSEDYPSA-UHFFFAOYSA-N 0.000 description 1
- 229960003749 ciclopirox Drugs 0.000 description 1
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 1
- 229960004022 clotrimazole Drugs 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229960003645 econazole nitrate Drugs 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 230000005669 field effect Effects 0.000 description 1
- 210000004905 finger nail Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000013021 overheating Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/02—Compresses or poultices for effecting heating or cooling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0001—Body part
- A61F2007/0029—Arm or parts thereof
- A61F2007/0037—Finger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0001—Body part
- A61F2007/0039—Leg or parts thereof
- A61F2007/0046—Toe
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0001—Body part
- A61F2007/0052—Body part for treatment of skin or hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0086—Heating or cooling appliances for medical or therapeutic treatment of the human body with a thermostat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0093—Heating or cooling appliances for medical or therapeutic treatment of the human body programmed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/007—Heating or cooling appliances for medical or therapeutic treatment of the human body characterised by electric heating
Definitions
- Nail disorders comprise about ten percent of all skin disorders and fungal nail infections (onychomycosis) account for approximately fifty percent of all nail problems. It is estimated that two to three percent of the United States population has onychomycosis. The disorder is twice as frequent among men and increases with age.
- Onychomycosis which causes the nails to become thickened, hard to cut and often painful, is worsened by moisture, warmth, trauma, communal bathing, and other activities that lead to the exposure to fungi.
- Common complaints of the disorder are pain, deformed nails, and interference with daily activities such as walking, typing, or playing a musical instrument.
- Fingernail infections have a significant effect on the life of infected individuals. Embarrassment may prevent patients from taking part in social situations because they feel unwilling to show their hands or feet.
- Onychomycosis typically refers to the invasion of the nail bed by a fungus
- the infection may be due to a fungus, a mold, or non-dermatophyte yeast.
- the group of fungi most commonly responsible for causing infection of the nail bed are known as dermatophytes and include the genera Trichophyton, Microsporum, and Epidermophyton.
- Infections can also be caused by Candidal species, which are yeasts.
- Candida species causing infection is Candida albicans.
- the most common non-dermatophyte molds associated with nail disease are Scopulariopsis, Scytalidium, Fusarium, Aspergillus and Onychocola canadensis.
- This method employed the use of hot water, heated to a temperature of 50 degrees Celsius, applied near the base of the nail for a period of 4 to 5 seconds repeated three times, approximately 15 seconds apart. Because of the thick nail plate and possible separation of the nail plate from the nail bed, this rapid, transient heat application is unlikely to have any appreciable effect on the fungal infection.
- This invention relates to the use of a regulated heat source that can be applied to a nail bed infection, such as onychomycosis, in order to initiate and/or accelerate the death of the bacteria, dermatophyte, mold, virus, or non-dermatophyte yeast causing the nail bed infection and thereby speed the recovery process.
- a nail bed infection such as onychomycosis
- a device for treating nail bed fungus includes a thermal delivery surface designed to be placed in contact with the nail plate.
- the thermal delivery surface is adapted to transfer thermal energy from the device to the nail bed.
- the thermal transfer medium is designed to be flexible, deformable, and highly conductive and is used to improved the transfer of thermal energy from the thermal delivery surface to the nail bed.
- Thermal transfer from the thermal delivery surface may further be enhanced by a spring tensioning system used to apply a downward pressure on the thermal delivery surface according to embodiments of the invention.
- a thermal gel can be applied to the air gap formed between the nail plate and nail bed. The combination of the thermal delivery surface, thermal transfer medium, thermal gel, and downward force of the spring tensioning system provide greatly improved thermal energy transfer.
- the thermal delivery surface is attached to the nail plate using a flexible strap.
- the flexible strap may be made of an elastic material and a fastening system is used to apply the thermal transfer surface to the nail plate.
- the flexible nature of the strap allows tension to be applied to the strap to produce a downward pressure on the thermal transfer surface.
- the transfer of thermal energy can also be improved by the use of a thermal transfer medium and thermal gel.
- FIGURE 1 shows a perspective view of an embodiment of a treatment device according to the present invention
- FIGURE 2 shows a perspective view of an embodiment of a thermal transfer kit for use with a treatment device according to the present invention
- FIGURES 3 A and 3B shows a nail bed, a nail plate, and an air gap between the two surfaces
- FIGURES 4A and 4B shows the filling of the air gap of FIGS. 3A and 3B and clamping of the thermal gel pack according to an embodiment of the present invention
- FIGURE 5 shows a perspective view of an embodiment of a flexible thermal strap for use with a treatment device according to the present invention
- FIGURE 6 shows a simplified block diagram of the major electrical components of an embodiment of the treatment device of FIGURE 1;
- FIGURE 7 is a diagram illustrating the control functionality of the firmware used in an embodiment of the present invention.
- FIGURE 8 shows a state diagram illustrating the operation of a treatment device according to an embodiment of the present invention.
- Treatment device 100 of a preferred embodiment operates to transfer thermal energy to the nail plate at a set temperature for a set period of time.
- the set temperature and set period of time can be varied to accommodate different disease conditions and patient tolerance levels.
- treatment device 100 can be can configured with permanent time and temperature settings selected to treat a specific type of nail bed infection.
- treatment device 100 preferably should be capable of heating a treatment surface to a temperature, as close as can be controlled using electrical heating with temperature feedback, between about 46 degrees Celsius and about 68 degrees Celsius and sustaining one or more temperatures for between about 10 seconds and about 30 minutes.
- thermal damage generally occurs when human skin is heated to a temperature of approximately 66 degrees Celsius or higher, an interface heated to this temperature or a higher temperature can nevertheless deliver an therapeutically effective amount of heat to the nail plate without resulting in thermal damage, depending on the amount of thermal energy delivered over a particular surface area and how readily the thermal energy is dissipated by the heated tissue.
- Treatment device 100 comprises a nail cover 112 connected by spring tensioning system 116 to housing 118.
- Thermal delivery surface 113, located under nail cover 112 also preferably includes a temperature sensor, not shown.
- Housing 118 comprises a protective cover to hold the internal electrical components of treatment device 100 (a preferred embodiment of which is shown and described below with respect to Fig. 6) and a user interface 122. By means of a user interface 122, the user may activate and monitor the device.
- Nail cover 112, thermal delivery surface 113, and spring tensions system 116 are replaceable according to embodiments of the invention. Nail cover 112 and thermal delivery surface 113 can be changed as necessary to accommodate the various differences in the size of the patent's digits (length of nail, width of nail, thickness of digit). Additionally, spring tensioning system 116 can be exchanged with various spring strengths as necessary for patient comfort.
- Thermal delivery surface 113 contains a heating element which is electrically connected to treatment device 100. Examples of heating elements include resistance heaters, etch foil heaters, silicone rubber heaters, heat cables, fiberglass heating tapes, wire wound flexible heaters, electric heating tape, cable heaters, tape heaters.
- Treatment device 100 provides electrical current to the heating element of thermal delivery surface 113 by means of rechargeable batteries.
- the heating element of thermal delivery surface 113 produces heat through electrical resistance, which, in turn, is monitored by treatment device 100.
- the temperature of thermal delivery surface 113 is monitored by a temperature sensor, which may be a thermistor or other electrical device that measures or monitors heat.
- Treatment device 100 is able to adjust the power provided to thermal delivery surface 113 so as to maintain thermal delivery surface 113 at or near a set temperature chosen for the treatment.
- housing 118 holds the internal electrical components and the power source, such as rechargeable batteries. " While treatment device 100 is described as using rechargeable batteries as the preferred power source, any suitable power source may be used, including receiving power from an ordinary household power plug and socket connection. A speaker, not shown, is also housed in housing 118.
- Treatment device 100 of the illustrated embodiment includes a battery charge port 130 and a data port 132.
- Battery charge port 130 is used to plug in a charger to charge the internal batteries or, in some embodiments, to power the device from line power.
- Data port 132 allows treatment device 100 to communicate with another device, such as a computer or PDA, and allows the internal electrical components to receive new programs or new data to be used in treatment device 100.
- Data that can be communicated from the device to a computer or PDA includes, but is not limited to, number of treatments, duration of treatment, temperature of treatment, date and time of treatment. Additionally, a computer or PDA can be used to change treatment settings such as duration, temperature, etc.
- User interface 120 of the illustrated embodiment includes power button 122, treatment button 124, and light emitting diodes (LEDs) 188.
- Power button 122 of one embodiment is used to turn treatment device 110 on and off.
- Treatment button 124 of the aforementioned embodiment is used to initiate and/or cancel treatments.
- Treatment button 124 can include LEDs 188 that indicate whether treatment device 10 is ready to begin a treatment. While the illustrated embodiment is shown using LEDs as a display, any display technology such as LCDs or other display may be used without departing from the concepts described herein.
- LEDs 188 could include an amber light to indicate that the device is not ready to begin a treatment and a green light to indicate that treatment device 100 is ready to begin a treatment.
- Treatment device 100 may comprise additional LEDs not shown to provide additional visual information to the user, such as the charge remaining in the battery and any other information which may be useful or interesting to the user.
- the speaker can be used to provide audible information to the user such as the amount of time remaining in the treatment, an error condition, low battery charge, and any other audible information that might be useful or interesting to the user.
- other user interfaces may also be used, including touch screens, slide controls, keyboards, light pens, microphones, speech recognition, pointing devices (mouse, track ball, etc.), and gesture devices.
- thermal transfer kit 200 includes thermal transfer medium to aid in the transfer of heat from the thermal delivery surface to the nail plate.
- the thermal transfer kit of the illustrated embodiment includes thermal gel packs 202, which, when applied to the nail plate, transfers thermal energy from thermal delivery surface 113 of FIGURE 1 sufficient to combat the bacteria, viruses, fungi, mold, and non-dermatophyte yeast known to contribute to nail bed infections.
- Thermal gel pack 202 of a preferred embodiment is flexible and conforms to the shape of the nail plate and has an adhesive surface 206, which, when removed from carrier 208 and applied to the nail plate holds the thermal gel pack on the nail plate.
- thermal gel packs 202 may include adhesive surface 204 to hold the gel pack to thermal delivery surface 113 of FIGURE 1.
- Thermal gel pack 202 may be a customizable gel pack which can be made to generally or specifically fit the nail bed of a particular patient. 10028] As shown in FIGURES 3A and 3B, the nail bed infection can often cause nail plate 302 to separate from nail bed 304, leaving an air gap 306 between the two surfaces. This air gap between nail plate 302 and nail bed 304 lowers the heat transferred to nail bed 304. Referring now to FIGURE 4, air gap 304 of FIGURE 3B may be filled with thermal gel 408 to improve heat transfer.
- the nail plate 402 may be gently lifted to allow thermal gel 408 to be introduced and fill the air gap between nail plate 402 and nail bed 404.
- Thermal gel 408 may be introduced using a syringe and needle, a tube with an applicator tip, sprayed in, or using any other means to fill air gap 304 of FIGURE 3 A.
- thermal gel 408 is used in combination with thermal gel pack 410 and thermal delivery surface 412.
- thermal gel pack 406 is applied to the nail plate 402, air gap 304 of FIGURE 3 A is filled with thermal gel 408, and the nail to be treated is placed in treatment device 100 of FIGURE 1.
- Nail cover 112 of FIGURE 1 applies a slight downward pressure on nail plate 402.
- the combination of filling the air gap with thermal gel 408, applying thermal gel pack 412 to nail plate 402, and applying a slight downward pressure using the clamping mechanism of nail cover 414 will noticeably improve heat transfer to the nail bed.
- an antifungal ingredient such as clotrimazole, ciclopirox, econazole nitrate, ketoconazole, myconazole nitrate, ketoconazole, or trebinafine hydrochloride may be added to the thermal gel formulation to improve the kill rate.
- an alternate means of applying a dose of thermal energy to the nail bed is by use of flexible strap 500 comprising a soft, flexible material designed to control tension and hold thermal delivery surface 502 against the nail plate or a thermal gel pack. Additionally, flexible strap 500 may be used in combination with thermal transfer media 406 and thermal gel 408 of Figure 4 to improve the heat transfer to the nail bed.
- Flexible strap 500 comprises a soft, flexible material 506 designed to conform to the irregular shapes of nail plates, and a fastening means 508 such as an adhesive fastening system or a mechanical fastening system.
- the use of adhesive fastening systems are well known in the art. Examples of these adhesive tape fastening systems are described in U.S. Patent No.
- Thermal delivery surface 502 contains a heating element which is electrically connected to the treatment device.
- thermal delivery surface 502 comprises a flexible material and flexible heating element also designed to conform to the irregular shape of nail plates.
- flexible heating elements include etch foil heaters, silicone rubber heaters, heat cables, fiberglass heating tapes, wire wound flexible heaters, electric heating tape, cable heaters, tape heaters.
- the heating element of thermal delivery surface 502 of the embodiments is electrically connected to a treatment device similar to treatment device 100 of FIGURE 1 by electrical connection 504.
- This electrical connection may be achieved, for example, by using a heater port in the housing like data port 132 of FIGURE 1.
- nail cover 112 and thermal delivery surface 113 of FIGURE 1 could be removed and replaced with flexible strap 500.
- the treatment device provides electrical current to thermal delivery surface 502 that produces heat through electrical resistance.
- the temperature of thermal delivery surface 502 is monitored by temperature sensor, not shown, which may be a thermistor or other electrical device that develops and regulates heat.
- the treatment device is able to adjust the power provided to thermal delivery surface 502 so as to maintain thermal delivery surface 502 at or near a set temperature and time chosen for the treatment.
- Treatment device 100 includes thermal delivery surface components mounted on circuit board 610.
- Thermal delivery surface components on circuit board 610 include the electrical components used to perform the treatment mounted on its surface.
- Circuit board 610 contains resistors, thermistors and other control components to develop and regulate heat.
- Resistors 612 mounted onto circuit board 610 are used to convert electrical energy from power source to heat energy needed to increase the temperature of thermal delivery surface 113, shown in FIGURE 1.
- Control of the temperature of thermal delivery surface 113 is done in response to signals from temperature sensor 614, mounted on circuit board 610.
- Temperature sensor 614 provides an electrical signal indicative of the temperature of thermal delivery surface 113 to microprocessor 620 in housing 118 of FIGURE 1.
- a memory element 616 may also mounted on circuit board 610.
- Memory element 616 can be any combination of processing and memory elements utilized to store and implement thermal delivery surface specific functions.
- Memory element 616 of the embodiments is used to store thermal delivery surface specific information.
- memory element 616 of the illustrated embodiment may include calibration information for its associated thermal delivery surface. As the individual components used in particular thermal delivery surface may have their own variances from their marked values, each thermal delivery surface is calibrated during manufacturing to provide calibration information stored in memory element 616 and used to adjust the heating algorithm of treatment device 100 to account for the particular values of the components in the thermal delivery surface.
- the memory element 616 can also store treatment variables such as treatment cycle duration, treatment temperature and treatment frequency, as well as other information that aids the treatment device in its operation.
- treatment variables such as treatment cycle duration, treatment temperature and treatment frequency, as well as other information that aids the treatment device in its operation.
- information can, for example, be information that identifies the type of thermal delivery surface and the intended treatment protocols, as well as algorithm information used during a treatment cycle.
- Microprocessor 620 is programmed to respond to and control the various inputs and outputs of treatment device 100 of FIGURE 1.
- Microprocessor 620 receives input from power button 642, and in response operates to power-up or power-down the treatment device accordingly.
- Microprocessor 620 also receives input from treatment button 644 and operates to start or stop treatment based on input from treatment button 644.
- LEDs 646 are turned on and off by microprocessor 620 to communicate visual information to the user, while speaker 630 is controlled by microprocessor 620 to communicate audible information to the user.
- Microprocessor 620 is also in electrical communication with thermal delivery surface 113 of FIGURE 1.
- microprocessor 620 communicates with memory element 616 and exchanges information on thermal delivery surface cycles, calibration, treatment variations and other thermal delivery surface specific information.
- Microprocessor 620 also preferably receives the signal from temperature sensor 614 through interface 632. Using the signal from temperature sensor 614, microprocessor 620 is operable to control the temperature of thermal delivery surface 113 of nail cover 112 of FIGURE 1 or thermal delivery surface 502 of FIGURE 5.
- Microprocessor 620 of the illustrated embodiment is connected to the gate of field effect transistor ("FET") 634, and by varying the voltage at the gate of FET 634 is able to control the amount of current flowing through resistors 612. The heat produced by resistors 612 is proportional to the amount of current passing through them.
- Thermal interlock 618 which can be a fuse having a maximum current rating chosen to prevent runaway overheating of resistors 612, provides a safety mechanism to ensure that the failure of temperature sensor 614 does not cause a dangerous operating temperature in the thermal delivery surface.
- Microprocessor 620 of the embodiments is programmed with a control algorithm referred to as a proportional, integral, derivative or PID.
- a PID is a control algorithm which uses three modes of operation: the proportional action is used to dampen the system response, the integral corrects for droop, and the derivative prevents overshoot and undershoot.
- the PID algorithm implemented in microprocessor 620 operates to bring the thermal delivery surface 113 to the desired operating temperature as quickly as possible with minimal overshoot, and also operates to respond to changes in the temperature of thermal delivery surface 113 during the treatment cycle that are caused by the heat sink effect of the treatment area.
- resistors 612 are connected to battery 622 through thermal interlock 618.
- Battery 622 which can be comprised of one or more individual cells, is charged by battery charger 624 when battery charger 624 is connected to external power supply 626.
- External power supply 626 can be any type of power supply, but is normally an AC to DC converter connected between battery charger 624 and an ordinary wall outlet.
- the nutnnt wittn ⁇ e of battery 622 is directly related to the amount of charge left in battery 622, therefore, by monitoring the voltage across battery 622 microprocessor 620 can determine the amount of charge remaining in battery 622 and convey this information to the user using LEDs 646 or speaker 630.
- Other methods of determining battery voltages or charge for different battery technologies can also be used and are well within the scope of the present invention.
- Firmware 700 represents the programming loaded on microprocessor 620. As described with reference to FIGURE 6, microprocessor 620 is operable to respond to and control the various aspects of treatment device 100 of FIGURE 1. Firmware 700 is able to accept inputs from power button 742, treatment button 744, temperature sensor 714 and battery 722. Firmware 700 is also able to exchange information with memory element 716, such as calibration data. The microprocessor 620 and memory element 716 may exchange any other information that may increase the efficacy of treatment device 100.
- firmware 700 controls FET 734 to regulate the temperature of the thermal delivery surface according to the PID algorithm programmed into firmware 700.
- Firmware 700 also controls speaker 730 to provide audible feedback to the user and LEDs 702 and 704 which are subsets of LEDs 646 from FIGURE 6, and provide indications of battery charge (LED 702) and treatment status (LEDs 704).
- FIGURE 8 a state transition diagram showing various operating states of firmware 700 from FIGURE 7 according to an embodiment is described.
- the state diagram begins a Suspended state 810 which is the power off state. During the power off mode the microprocessor is still receiving some power to allow it to monitor the power button.
- the Suspended state 810 is left when the power on button is pressed, and the state proceeds to the Processing Thermal delivery Surface Memory state 812.
- the microprocessor 630 and memory element 616 from FIGURE 6 exchange thermal delivery surface specific treatment information. If the thermal delivery surface usage count is not low or zero, the state passes to Heating state 816.
- the state progresses to the Warning state 814, which provides visual and or audible signals to the user to indicate that the thermal delivery surface usage count is low or zero. If the thermal delivery surface usage count is zero or the thermal delivery surface is removed, the state passes from the Warning state 814 to the Suspended state 810. If the thermal delivery surface uses count is low, but not zero the state passes from the Warning state 814 to the Heating state 816.
- the thermal delivery surface is heated using resistors 612 from FIGURE 6.
- a predictive model is used to set a timer based on the amount of time that should be required for the thermal delivery surface to come to temperature. This timer acts as in indicator that the thermal mass is responding to the heating correctly. If the thermal delivery surface does not reach the predetermined operating temperature by the expiration of the timer, it is an indication of a potentially faulty component and the treatment device shuts down by transitioning to Suspended state 810. Other predictions of thermal mass behavior can also be used to detect potentially faulty components.
- the treatment device powers down by transitioning to the Suspended state if the power button is pressed, or the battery voltage falls below a threshold, and indication of the fault is provided to the user through visual and/or audible signals. If the thermal delivery surface successfully reaches the operating temperature within the designated time the state transitions to Ready state 818. A timer is started upon entering the Ready state 818. If the timer expires or the power button is pressed while in the Ready state 818, the state transitions to the Suspended state 810.
- Treatment state 820 If the treatment button is pressed while in Ready state 818 the state transitions to Treatment state 820. Two timers, a treatment timer and a safety timer, are started upon entering the Treatment state 820.
- the safety timer is slightly longer than the treatment timer so that if there is a failure in the treatment timer the safety timer will expire and transition the state to the Power Reset state 824 before transitioning to the Suspended state 810.
- the state also transitions from Treatment state 820 to Suspended state 810 if the power button is pressed during a treatment cycle.
- the treatment device can also be programmed to provide visual and/or audible indications of the progress of the treatment timer.
- speaker 630 of FIGURE 6 can be used to provide intermittent tones during the treatment to let the user know that the treatment is continuing.
- the time between the tones could be spaced to provide an indication of the remaining time in the treatment cycle, such as by shortening the time between the tones as the cycle gets closer to the end.
- Many other methods of providing visual or audible feedback could be contemplated and are well within the scope of the present invention.
- the state transitions from Treatment state 820 to Wait state 822 which forces an inter-treatment delay. If the power button is pressed or the thermal delivery surface removed during the Wait state, the state transitions to Suspended state 810. After the expiration of the inter-treatment delay the state transitions back to Ready state 818.
- the Wait state 822 can be used to force a temporal treatment limit. While the inter-treatment delay forces a relatively brief delay between treatment cycles, the temporal treatment limit acts to limit the number of treatments that can be performed in specified period. For example, if the treatment cycle is two and a half minutes and the inter-treatment delay is 10 seconds, a temporal treatment limit of 30 minutes could be used to limit the device to approximately 10 to 11 consecutive treatments before a forced interval is imposed.
- an antibacterial, antiseptic, or antifungal compound may be introduced at air gap between the nail plate and nail bed, adding to the killing effect provided by the thermal energy.
- the heat created by thermal delivery surface 113 will aid in the dispersing and absorbing of such compounds creating a synergistic effect.
- thermo gel pack 502 of FIGURE 2.
- the temperature of the thermal gel pack could be used to control the thermal energy transferred to the nail bed infection.
- a temperature sensor could be located in the thermal gel 408 filling the air gap.
- pseudo sensors are also possible. For example, the temperature of the thermal contact surface or thermal transfer medium could be predicted based on measurement of the power supplied to the heating element and the physical properties of the heating element.
- the set temperature and treatment time should be sufficient to cause a thermal reaction or response in the fungus, virus or bacteria detrimentally affecting the skin surface.
- the set temperature and treatment time should be below the threshold that would damage the skin being treated.
- the first factor is discussed with reference to Examples 1-3 below using exemplary infectious agents. Based on Examples 1-3 a set temperature of 121 degrees Fahrenheit (49.44 degrees Celsius) for a period of 150 seconds proves to be effective for a variety of infectious agent and irritants. While a set temperature of 121 degrees Fahrenheit and a treatment time of 150 seconds are chosen for an embodiment of the present invention, other embodiments using combinations of set temperatures and treatment times which depart significantly from the described embodiment are well within the scope of the present invention.
- the plot of 49.44 degrees Celsius at 1 ⁇ O seconds is just under the dashed curve representing "the first morphological evidence of thermal damage," such as slight reddening.
- the curve indicates that the first reversible damage occurs at 195 seconds.
- the set temperature and treatment time are safe, and at worse might produce slight reddening of the treatment area.
- the bacterial strain P. acnes was purchased from The American Type Culture Collection ATCC (No. 11827, Lot 419571, Manassas, VA). The cultures were stored in KWIK-STIK lyophilized preparations. The lyophilized cells (P. acnes) were rehydrated according to the manufacturers recommendations and initially grown on a streak plate to isolate individual colonies under anaerobic conditions. These plates were then incubated overnight at 37 degrees Celsius in an anaerobic chamber. Individual colonies were then isolated and inoculated into TSB-growth media with medium agitation overnight. From these aliquots of 0.1 ml of TSB broth culture was arfrlerl to the 0.9 ml of PBS sterile buffer.
- FIGURE 10 demonstrates the rapid decline of P. acnes in response to various temperatures and duration of treatment.
- the baseline P. acnes colony count that had not been exposed to the heat source was 1050.
- Results A general trend of reduction of required time to kill the bacterial strain is seen at higher temperature incubations. Also of note is the temporal thermal threshold where the number of colonies drops off in a very steep fashion. By using the curves generated by such experiments the optimal thermal output and the timing for each temperature can be extrapolated for a localized heating device.
- the in vitro data shown demonstrates significant sensitivity of P. acnes bacterial cells to the effects of sustained low-level heat. Temperatures of 55 degrees Celsius result in the death of substantially all of the bacteria after ZVz minutes. Temperatures of 58 and 59 degrees Celsius result in the death of substantially all of the bacteria after 2 minutes. These curves demonstrate that P, acnes can be rendered largely non-viable by treatment under the conditions shown by the death curves.
- the treatment consisted of a 2 H minute application of the device to the lesion site.
- the study called for the application of two treatment cycles to each patient, with the second treatment cycle being administered 12 hours after the first.
- the treatments were frequently only conducted once on each subject because twelve hours after the first treatment many of the lesions had healed to an extent that they did not require any further treatment,
- Results of experiments performed on volunteer subjects are listed in Table 1. Members of the control group were not treated. Members of the treatment group were treated as described above. Both groups either examined or self-reported the results of treatment over the following 14 days. Only results from study participants who reported data for 14 days were included in the table. The data is reported in terms of the size of the lesion prior to treatment. A lesion size of 100% indicates that the lesion size was unchanged. Lesion size was approximated in increments of 10%. A lesion size of 0% indicates that the lesion had fully healed.
- the inventors have tested prototype devices on multiple oral herpes lesions of human volunteers, and the results have shown a complete termination of the herpetic lesion after two applications of the device at 2 1/2 minutes per treatment, 12 hours apart, as described in Example 2.
- the volunteers reported a marked decrease in healing time after treatment versus the usual healing cycle for lesions of this type.
Landscapes
- Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Thermal Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Thermotherapy And Cooling Therapy Devices (AREA)
Abstract
A regulated heat source is described that can be applied to the nail bed in order to accelerate the death of the organisms known to contribute to nail bed infections.
Description
BACKGROUND OF THE INVENTION
[0002] Nail disorders comprise about ten percent of all skin disorders and fungal nail infections (onychomycosis) account for approximately fifty percent of all nail problems. It is estimated that two to three percent of the United States population has onychomycosis. The disorder is twice as frequent among men and increases with age.
[0003] Onychomycosis, which causes the nails to become thickened, hard to cut and often painful, is worsened by moisture, warmth, trauma, communal bathing, and other activities that lead to the exposure to fungi. Common complaints of the disorder are pain, deformed nails, and interference with daily activities such as walking, typing, or playing a musical instrument. Those who suffer from onychomycosis cite a substantial negative effect on their quality of life. Fingernail infections have a significant effect on the life of infected individuals. Embarrassment may prevent patients from taking part in social situations because they feel unwilling to show their hands or feet.
[0004] While Onychomycosis typically refers to the invasion of the nail bed by a fungus, the infection may be due to a fungus, a mold, or non-dermatophyte yeast. The group of fungi most commonly responsible for causing infection of the nail bed are known as dermatophytes and include the genera Trichophyton, Microsporum, and Epidermophyton. Infections can also be caused by Candidal species, which are yeasts. The most common Candida species causing infection is Candida albicans. The most common non-dermatophyte molds associated with nail disease are Scopulariopsis, Scytalidium, Fusarium, Aspergillus and Onychocola canadensis.
[0005] Until now, the methods and devices for treating onychomycosis have included treatment with topical antifungal agents, oral antifungal drugs, thinning or partial removal of the nail, and permanent removal of the nail. Often, these techniques take up to year to no longer see the symptoms of onychomycosis.
[0006] It has been demonstrated that the application of heat at various time and temperature combinations reliably kills the P. acnes and Staphylococcus aureus bacteria, as well as the HSVl virus. The necessary temperature range to kill bacteria is generally above 47 degrees Celsius, but below the burn or discomfort threshold for
human skin. Depending on the area of skin and the area of surface contact, this upper threshold is in the range of 51 degrees Celsius. A treatment method using a rapid, transient heat application, has been suggested for the treatment of onychomycosis (Chato, LC, Thermal Therapy of Toe Nail Fungus, Int'l Mech. Eng. Congress and Exposition 2000, November 11-16, 2000, Orlando, Florida). This method employed the use of hot water, heated to a temperature of 50 degrees Celsius, applied near the base of the nail for a period of 4 to 5 seconds repeated three times, approximately 15 seconds apart. Because of the thick nail plate and possible separation of the nail plate from the nail bed, this rapid, transient heat application is unlikely to have any appreciable effect on the fungal infection.
BRIEF SUMMARY OF THE INVENTION
[0007] This invention relates to the use of a regulated heat source that can be applied to a nail bed infection, such as onychomycosis, in order to initiate and/or accelerate the death of the bacteria, dermatophyte, mold, virus, or non-dermatophyte yeast causing the nail bed infection and thereby speed the recovery process.
[0008] In one embodiment, a device for treating nail bed fungus is described. The device includes a thermal delivery surface designed to be placed in contact with the nail plate. The thermal delivery surface is adapted to transfer thermal energy from the device to the nail bed. There may also be a thermal transfer medium that is attached to the nail plate. The thermal transfer medium is designed to be flexible, deformable, and highly conductive and is used to improved the transfer of thermal energy from the thermal delivery surface to the nail bed. Thermal transfer from the thermal delivery surface may further be enhanced by a spring tensioning system used to apply a downward pressure on the thermal delivery surface according to embodiments of the invention. In situations were the nail plate has separate from the nail bed, a thermal gel can be applied to the air gap formed between the nail plate and nail bed. The combination of the thermal delivery surface, thermal transfer medium, thermal gel, and downward force of the spring tensioning system provide greatly improved thermal energy transfer.
[0009] In another embodiment, the thermal delivery surface is attached to the nail plate using a flexible strap. The flexible strap may be made of an elastic material and a fastening system is used to apply the thermal transfer surface to the nail plate. The flexible nature of the strap allows tension to be applied to the strap to produce a downward pressure on the thermal transfer surface. As discussed above, the transfer of thermal energy can also be improved by the use of a thermal transfer medium and thermal gel.
[0010] The foregoing has outlined rather broadly the features and technical advantages of the present invention in order that the detailed description of the invention that follows may be better understood. Additional features and advantages of the invention will be described hereinafter which form the subject of the claims of the
invention. It should be appreciated by those skilled in the art that the conception and specific embodiment disclosed may be readily utilized as a basis for modifying or designing other structures for carrying out the same purposes of the present invention. It should also be realized by those skilled in the art that such equivalent constructions do not depart from the spirit and scope of the invention as set forth in the appended claims. The novel features which are believed to be characteristic of the invention, both as to its organization and method of operation, together with further objects and advantages will be better understood from the following description when considered in connection with the accompanying figures. It is to be expressly understood, however, that each of the figures is provided for the purpose of illustration and description only and is not intended as a definition of the limits of the present invention.
BRIEF DESCRIPTION OF THE DRAWINGS
[0011] The following drawings form part of the present specification and are included to further demonstrate certain aspects of the present invention. The invention may be better understood by reference to one or more of these drawings in combination with the detailed description of specific embodiments presented herein.
[0012] FIGURE 1 shows a perspective view of an embodiment of a treatment device according to the present invention;
[0013] FIGURE 2 shows a perspective view of an embodiment of a thermal transfer kit for use with a treatment device according to the present invention;
[0014] FIGURES 3 A and 3B shows a nail bed, a nail plate, and an air gap between the two surfaces;
[0015] FIGURES 4A and 4B shows the filling of the air gap of FIGS. 3A and 3B and clamping of the thermal gel pack according to an embodiment of the present invention;
[0016] FIGURE 5 shows a perspective view of an embodiment of a flexible thermal strap for use with a treatment device according to the present invention;
[0017] FIGURE 6 shows a simplified block diagram of the major electrical components of an embodiment of the treatment device of FIGURE 1;
[0018] FIGURE 7 is a diagram illustrating the control functionality of the firmware used in an embodiment of the present invention; and
[0019] FIGURE 8 shows a state diagram illustrating the operation of a treatment device according to an embodiment of the present invention.
DETAILED DESCRIPTION OF THE INVENTION
[0020] An embodiment of a device for treating or preventing nail bed infections is shown in FIGURE 1. Treatment device 100 of a preferred embodiment operates to transfer thermal energy to the nail plate at a set temperature for a set period of time. The set temperature and set period of time can be varied to accommodate different disease conditions and patient tolerance levels. Alternatively, treatment device 100 can be can configured with permanent time and temperature settings selected to treat a specific type of nail bed infection. However, treatment device 100 preferably should be capable of heating a treatment surface to a temperature, as close as can be controlled using electrical heating with temperature feedback, between about 46 degrees Celsius and about 68 degrees Celsius and sustaining one or more temperatures for between about 10 seconds and about 30 minutes. Although thermal damage generally occurs when human skin is heated to a temperature of approximately 66 degrees Celsius or higher, an interface heated to this temperature or a higher temperature can nevertheless deliver an therapeutically effective amount of heat to the nail plate without resulting in thermal damage, depending on the amount of thermal energy delivered over a particular surface area and how readily the thermal energy is dissipated by the heated tissue.
[0021] Treatment device 100 comprises a nail cover 112 connected by spring tensioning system 116 to housing 118. Thermal delivery surface 113, located under nail cover 112 also preferably includes a temperature sensor, not shown. Housing 118 comprises a protective cover to hold the internal electrical components of treatment device 100 (a preferred embodiment of which is shown and described below with respect to Fig. 6) and a user interface 122. By means of a user interface 122, the user may activate and monitor the device.
[0022] Nail cover 112, thermal delivery surface 113, and spring tensions system 116 are replaceable according to embodiments of the invention. Nail cover 112 and thermal delivery surface 113 can be changed as necessary to accommodate the various differences in the size of the patent's digits (length of nail, width of nail, thickness of digit). Additionally, spring tensioning system 116 can be exchanged with various spring strengths as necessary for patient comfort.
[0023] Thermal delivery surface 113 contains a heating element which is electrically connected to treatment device 100. Examples of heating elements include resistance heaters, etch foil heaters, silicone rubber heaters, heat cables, fiberglass heating tapes, wire wound flexible heaters, electric heating tape, cable heaters, tape heaters. Treatment device 100 provides electrical current to the heating element of thermal delivery surface 113 by means of rechargeable batteries. The heating element of thermal delivery surface 113 produces heat through electrical resistance, which, in turn, is monitored by treatment device 100. The temperature of thermal delivery surface 113 is monitored by a temperature sensor, which may be a thermistor or other electrical device that measures or monitors heat. Treatment device 100 is able to adjust the power provided to thermal delivery surface 113 so as to maintain thermal delivery surface 113 at or near a set temperature chosen for the treatment.
[0024] As noted above, housing 118 holds the internal electrical components and the power source, such as rechargeable batteries. "While treatment device 100 is described as using rechargeable batteries as the preferred power source, any suitable power source may be used, including receiving power from an ordinary household power plug and socket connection. A speaker, not shown, is also housed in housing 118.
[0025] Treatment device 100 of the illustrated embodiment includes a battery charge port 130 and a data port 132. Battery charge port 130 is used to plug in a charger to charge the internal batteries or, in some embodiments, to power the device from line power. Data port 132 allows treatment device 100 to communicate with another device, such as a computer or PDA, and allows the internal electrical components to receive new programs or new data to be used in treatment device 100. Data that can be communicated from the device to a computer or PDA includes, but is not limited to, number of treatments, duration of treatment, temperature of treatment, date and time of treatment. Additionally, a computer or PDA can be used to change treatment settings such as duration, temperature, etc. Although the embodiment shown in FIGURE 1 contains battery charge port 130 and data port 132 on the side of housing 118, battery charge port 130 and data port 132 may be found in another location of housing 118.
[0026] User interface 120 of the illustrated embodiment includes power button 122, treatment button 124, and light emitting diodes (LEDs) 188. Power button 122 of one embodiment is used to turn treatment device 110 on and off. Treatment button 124 of the aforementioned embodiment is used to initiate and/or cancel treatments. Treatment button 124 can include LEDs 188 that indicate whether treatment device 10 is ready to begin a treatment. While the illustrated embodiment is shown using LEDs as a display, any display technology such as LCDs or other display may be used without departing from the concepts described herein. For example, LEDs 188 could include an amber light to indicate that the device is not ready to begin a treatment and a green light to indicate that treatment device 100 is ready to begin a treatment. Treatment device 100 may comprise additional LEDs not shown to provide additional visual information to the user, such as the charge remaining in the battery and any other information which may be useful or interesting to the user. The speaker can be used to provide audible information to the user such as the amount of time remaining in the treatment, an error condition, low battery charge, and any other audible information that might be useful or interesting to the user. Additionally, other user interfaces may also be used, including touch screens, slide controls, keyboards, light pens, microphones, speech recognition, pointing devices (mouse, track ball, etc.), and gesture devices.
[0027] Referring now to FIGURE 2, an embodiment of a thermal transfer kit 200 is shown. The thermal transfer kit includes thermal transfer medium to aid in the transfer of heat from the thermal delivery surface to the nail plate. The thermal transfer kit of the illustrated embodiment includes thermal gel packs 202, which, when applied to the nail plate, transfers thermal energy from thermal delivery surface 113 of FIGURE 1 sufficient to combat the bacteria, viruses, fungi, mold, and non-dermatophyte yeast known to contribute to nail bed infections. Thermal gel pack 202 of a preferred embodiment is flexible and conforms to the shape of the nail plate and has an adhesive surface 206, which, when removed from carrier 208 and applied to the nail plate holds the thermal gel pack on the nail plate. Additionally or alternatively, thermal gel packs 202 may include adhesive surface 204 to hold the gel pack to thermal delivery surface 113 of FIGURE 1. Thermal gel pack 202 may be a customizable gel pack which can be made to generally or specifically fit the nail bed of a particular patient.
10028] As shown in FIGURES 3A and 3B, the nail bed infection can often cause nail plate 302 to separate from nail bed 304, leaving an air gap 306 between the two surfaces. This air gap between nail plate 302 and nail bed 304 lowers the heat transferred to nail bed 304. Referring now to FIGURE 4, air gap 304 of FIGURE 3B may be filled with thermal gel 408 to improve heat transfer. The nail plate 402 may be gently lifted to allow thermal gel 408 to be introduced and fill the air gap between nail plate 402 and nail bed 404. Thermal gel 408 may be introduced using a syringe and needle, a tube with an applicator tip, sprayed in, or using any other means to fill air gap 304 of FIGURE 3 A. To further improve the heat transfer to the nail bed, thermal gel 408 is used in combination with thermal gel pack 410 and thermal delivery surface 412.
[0029] In operation according to a preferred embodiment, thermal gel pack 406 is applied to the nail plate 402, air gap 304 of FIGURE 3 A is filled with thermal gel 408, and the nail to be treated is placed in treatment device 100 of FIGURE 1. Nail cover 112 of FIGURE 1 applies a slight downward pressure on nail plate 402. The combination of filling the air gap with thermal gel 408, applying thermal gel pack 412 to nail plate 402, and applying a slight downward pressure using the clamping mechanism of nail cover 414 will noticeably improve heat transfer to the nail bed. Further, an antifungal ingredient such as clotrimazole, ciclopirox, econazole nitrate, ketoconazole, myconazole nitrate, ketoconazole, or trebinafine hydrochloride may be added to the thermal gel formulation to improve the kill rate.
[0030] Now referring to FIGURE 5, an alternate means of applying a dose of thermal energy to the nail bed is by use of flexible strap 500 comprising a soft, flexible material designed to control tension and hold thermal delivery surface 502 against the nail plate or a thermal gel pack. Additionally, flexible strap 500 may be used in combination with thermal transfer media 406 and thermal gel 408 of Figure 4 to improve the heat transfer to the nail bed. Flexible strap 500 comprises a soft, flexible material 506 designed to conform to the irregular shapes of nail plates, and a fastening means 508 such as an adhesive fastening system or a mechanical fastening system. The use of adhesive fastening systems are well known in the art. Examples of these adhesive tape fastening systems are described in U.S. Patent No. 3,848,592 entitled "Tape Fastening Systems for Disposable Diaper" issued to Kenneth B. Buell on Nov. 19, 1974; and TT S Patent No. 5,413,568 entitled "Refastenable adhesive fastening systems for
individually packaged disposable absorbent articles" issued to Jennifer A. Roach et al. Examples of mechanical fastening system are also well known in the art. Examples include buttons, snaps, or hook and loop-type mechanical fasteners.
[0031] Thermal delivery surface 502 contains a heating element which is electrically connected to the treatment device. Preferably, thermal delivery surface 502 comprises a flexible material and flexible heating element also designed to conform to the irregular shape of nail plates. Examples of flexible heating elements include etch foil heaters, silicone rubber heaters, heat cables, fiberglass heating tapes, wire wound flexible heaters, electric heating tape, cable heaters, tape heaters.
[0032] The heating element of thermal delivery surface 502 of the embodiments is electrically connected to a treatment device similar to treatment device 100 of FIGURE 1 by electrical connection 504. This electrical connection may be achieved, for example, by using a heater port in the housing like data port 132 of FIGURE 1. Alternatively, nail cover 112 and thermal delivery surface 113 of FIGURE 1 could be removed and replaced with flexible strap 500. The treatment device provides electrical current to thermal delivery surface 502 that produces heat through electrical resistance. The temperature of thermal delivery surface 502 is monitored by temperature sensor, not shown, which may be a thermistor or other electrical device that develops and regulates heat. The treatment device is able to adjust the power provided to thermal delivery surface 502 so as to maintain thermal delivery surface 502 at or near a set temperature and time chosen for the treatment.
[0033] Referring now to FIGURE 6, an electrical block diagram showing an embodiment of the electrical system of treatment device 100 of FIGURE 1 is shown. Treatment device 100 includes thermal delivery surface components mounted on circuit board 610. Thermal delivery surface components on circuit board 610 include the electrical components used to perform the treatment mounted on its surface. Circuit board 610 contains resistors, thermistors and other control components to develop and regulate heat. Resistors 612 mounted onto circuit board 610 are used to convert electrical energy from power source to heat energy needed to increase the temperature of thermal delivery surface 113, shown in FIGURE 1. Control of the temperature of thermal delivery surface 113 is done in response to signals from temperature sensor 614,
mounted on circuit board 610. Temperature sensor 614 provides an electrical signal indicative of the temperature of thermal delivery surface 113 to microprocessor 620 in housing 118 of FIGURE 1.
[0034] A memory element 616 may also mounted on circuit board 610. Memory element 616 can be any combination of processing and memory elements utilized to store and implement thermal delivery surface specific functions. Memory element 616 of the embodiments is used to store thermal delivery surface specific information. For example, memory element 616 of the illustrated embodiment may include calibration information for its associated thermal delivery surface. As the individual components used in particular thermal delivery surface may have their own variances from their marked values, each thermal delivery surface is calibrated during manufacturing to provide calibration information stored in memory element 616 and used to adjust the heating algorithm of treatment device 100 to account for the particular values of the components in the thermal delivery surface.
[0035] The memory element 616 can also store treatment variables such as treatment cycle duration, treatment temperature and treatment frequency, as well as other information that aids the treatment device in its operation. Such information can, for example, be information that identifies the type of thermal delivery surface and the intended treatment protocols, as well as algorithm information used during a treatment cycle.
[0036] An electrical diagram showing an embodiment of the electrical system 610 of treatment device 100 of FIGURE 1 is also illustrated in FIGURE 6. Microprocessor 620 is programmed to respond to and control the various inputs and outputs of treatment device 100 of FIGURE 1. Microprocessor 620 receives input from power button 642, and in response operates to power-up or power-down the treatment device accordingly. Microprocessor 620 also receives input from treatment button 644 and operates to start or stop treatment based on input from treatment button 644. LEDs 646 are turned on and off by microprocessor 620 to communicate visual information to the user, while speaker 630 is controlled by microprocessor 620 to communicate audible information to the user.
[0037] Microprocessor 620 is also in electrical communication with thermal delivery surface 113 of FIGURE 1. In operation according to a preferred embodiment, microprocessor 620 communicates with memory element 616 and exchanges information on thermal delivery surface cycles, calibration, treatment variations and other thermal delivery surface specific information. Microprocessor 620 also preferably receives the signal from temperature sensor 614 through interface 632. Using the signal from temperature sensor 614, microprocessor 620 is operable to control the temperature of thermal delivery surface 113 of nail cover 112 of FIGURE 1 or thermal delivery surface 502 of FIGURE 5. Microprocessor 620 of the illustrated embodiment is connected to the gate of field effect transistor ("FET") 634, and by varying the voltage at the gate of FET 634 is able to control the amount of current flowing through resistors 612. The heat produced by resistors 612 is proportional to the amount of current passing through them. Thermal interlock 618, which can be a fuse having a maximum current rating chosen to prevent runaway overheating of resistors 612, provides a safety mechanism to ensure that the failure of temperature sensor 614 does not cause a dangerous operating temperature in the thermal delivery surface.
[0038] Microprocessor 620 of the embodiments is programmed with a control algorithm referred to as a proportional, integral, derivative or PID. A PID is a control algorithm which uses three modes of operation: the proportional action is used to dampen the system response, the integral corrects for droop, and the derivative prevents overshoot and undershoot. The PID algorithm implemented in microprocessor 620 operates to bring the thermal delivery surface 113 to the desired operating temperature as quickly as possible with minimal overshoot, and also operates to respond to changes in the temperature of thermal delivery surface 113 during the treatment cycle that are caused by the heat sink effect of the treatment area.
[0039] In addition to being connected to FET 634, resistors 612 are connected to battery 622 through thermal interlock 618. Battery 622, which can be comprised of one or more individual cells, is charged by battery charger 624 when battery charger 624 is connected to external power supply 626. External power supply 626 can be any type of power supply, but is normally an AC to DC converter connected between battery charger 624 and an ordinary wall outlet. According to embodiments, the nutnnt wittnσe of battery 622 is directly related to the amount of charge left in battery
622, therefore, by monitoring the voltage across battery 622 microprocessor 620 can determine the amount of charge remaining in battery 622 and convey this information to the user using LEDs 646 or speaker 630. Other methods of determining battery voltages or charge for different battery technologies can also be used and are well within the scope of the present invention.
[0040] Referring now to FIGURE 7, a diagram showing the various inputs to the firmware run by embodiments of microprocessor 620 of FIGURE 6 is described. Firmware 700 represents the programming loaded on microprocessor 620. As described with reference to FIGURE 6, microprocessor 620 is operable to respond to and control the various aspects of treatment device 100 of FIGURE 1. Firmware 700 is able to accept inputs from power button 742, treatment button 744, temperature sensor 714 and battery 722. Firmware 700 is also able to exchange information with memory element 716, such as calibration data. The microprocessor 620 and memory element 716 may exchange any other information that may increase the efficacy of treatment device 100.
[0041] In response to the temperature sensor input and information from memory element 716, firmware 700 controls FET 734 to regulate the temperature of the thermal delivery surface according to the PID algorithm programmed into firmware 700. Firmware 700 also controls speaker 730 to provide audible feedback to the user and LEDs 702 and 704 which are subsets of LEDs 646 from FIGURE 6, and provide indications of battery charge (LED 702) and treatment status (LEDs 704).
[0042] Referring now to FIGURE 8, a state transition diagram showing various operating states of firmware 700 from FIGURE 7 according to an embodiment is described. The state diagram begins a Suspended state 810 which is the power off state. During the power off mode the microprocessor is still receiving some power to allow it to monitor the power button. The Suspended state 810 is left when the power on button is pressed, and the state proceeds to the Processing Thermal delivery Surface Memory state 812. In the Processing Thermal delivery Surface Memory state 812 the microprocessor 630 and memory element 616 from FIGURE 6 exchange thermal delivery surface specific treatment information. If the thermal delivery surface usage count is not low or zero, the state passes to Heating state 816. If the thermal delivery surface usage count is found to be low or zero the state progresses to the Warning state
814, which provides visual and or audible signals to the user to indicate that the thermal delivery surface usage count is low or zero. If the thermal delivery surface usage count is zero or the thermal delivery surface is removed, the state passes from the Warning state 814 to the Suspended state 810. If the thermal delivery surface uses count is low, but not zero the state passes from the Warning state 814 to the Heating state 816.
[0043] During the Heating state 816 the thermal delivery surface is heated using resistors 612 from FIGURE 6. A predictive model is used to set a timer based on the amount of time that should be required for the thermal delivery surface to come to temperature. This timer acts as in indicator that the thermal mass is responding to the heating correctly. If the thermal delivery surface does not reach the predetermined operating temperature by the expiration of the timer, it is an indication of a potentially faulty component and the treatment device shuts down by transitioning to Suspended state 810. Other predictions of thermal mass behavior can also be used to detect potentially faulty components.
[0044] In addition to the expiration of the timer, the treatment device powers down by transitioning to the Suspended state if the power button is pressed, or the battery voltage falls below a threshold, and indication of the fault is provided to the user through visual and/or audible signals. If the thermal delivery surface successfully reaches the operating temperature within the designated time the state transitions to Ready state 818. A timer is started upon entering the Ready state 818. If the timer expires or the power button is pressed while in the Ready state 818, the state transitions to the Suspended state 810.
[0045] If the treatment button is pressed while in Ready state 818 the state transitions to Treatment state 820. Two timers, a treatment timer and a safety timer, are started upon entering the Treatment state 820. The safety timer is slightly longer than the treatment timer so that if there is a failure in the treatment timer the safety timer will expire and transition the state to the Power Reset state 824 before transitioning to the Suspended state 810. The state also transitions from Treatment state 820 to Suspended state 810 if the power button is pressed during a treatment cycle.
[0046] As a treatment cycle can be a relatively long period of time, the treatment device can also be programmed to provide visual and/or audible indications of the progress of the treatment timer. For example, speaker 630 of FIGURE 6 can be used to provide intermittent tones during the treatment to let the user know that the treatment is continuing. The time between the tones could be spaced to provide an indication of the remaining time in the treatment cycle, such as by shortening the time between the tones as the cycle gets closer to the end. Many other methods of providing visual or audible feedback could be contemplated and are well within the scope of the present invention.
[0047] When the treatment timer expires, or if the treatment button is pressed, the state transitions from Treatment state 820 to Wait state 822 which forces an inter-treatment delay. If the power button is pressed or the thermal delivery surface removed during the Wait state, the state transitions to Suspended state 810. After the expiration of the inter-treatment delay the state transitions back to Ready state 818. In addition to the inter-treatment delay, the Wait state 822 can be used to force a temporal treatment limit. While the inter-treatment delay forces a relatively brief delay between treatment cycles, the temporal treatment limit acts to limit the number of treatments that can be performed in specified period. For example, if the treatment cycle is two and a half minutes and the inter-treatment delay is 10 seconds, a temporal treatment limit of 30 minutes could be used to limit the device to approximately 10 to 11 consecutive treatments before a forced interval is imposed.
[0048] In another embodiment of the treatment device 100, an antibacterial, antiseptic, or antifungal compound may be introduced at air gap between the nail plate and nail bed, adding to the killing effect provided by the thermal energy. In turn, the heat created by thermal delivery surface 113 will aid in the dispersing and absorbing of such compounds creating a synergistic effect.
[0049] Although the preferred embodiments described above disclose the use of a temperature sensor which measures the temperature of the thermal delivery surface, other locations of the temperature sensor are well within the scope of this invention. Other locations include a temperature sensor located in the thermal transfer medium, such as thermal gel pack 502 of FIGURE 2. By locating the temperature sensor
in thermal gel pack 502, the temperature of the thermal gel pack could be used to control the thermal energy transferred to the nail bed infection. If the nail plate 402 has separated from the nail bed 404, such as shown in 4B, a temperature sensor could be located in the thermal gel 408 filling the air gap. Additionally, pseudo sensors are also possible. For example, the temperature of the thermal contact surface or thermal transfer medium could be predicted based on measurement of the power supplied to the heating element and the physical properties of the heating element.
Preferred Set Temperature and Treatment Time
[0050] To determine the preferred set temperature and treatment time, two factors should be considered. First, the set temperature and treatment time should be sufficient to cause a thermal reaction or response in the fungus, virus or bacteria detrimentally affecting the skin surface. Second, the set temperature and treatment time should be below the threshold that would damage the skin being treated. The first factor is discussed with reference to Examples 1-3 below using exemplary infectious agents. Based on Examples 1-3 a set temperature of 121 degrees Fahrenheit (49.44 degrees Celsius) for a period of 150 seconds proves to be effective for a variety of infectious agent and irritants. While a set temperature of 121 degrees Fahrenheit and a treatment time of 150 seconds are chosen for an embodiment of the present invention, other embodiments using combinations of set temperatures and treatment times which depart significantly from the described embodiment are well within the scope of the present invention.
[0051] To ensure that the described embodiment of a set time and temperature do not cause burn damage to the treatment area, modeling can be performed against previous research done into burn injuries. The modeling assumes that the skin surface in contact with the applicator immediately reaches the applicator temperature of 121 degrees Fahrenheit and remains at that temperature for the entire 150 seconds. First, the set temperature and treatment time are plotted against the Time- Surface Temperature Thresholds plot represented in FIGURE 4, page 711 from Moritz and Henriques, "Studies of Thermal Energy," American Journal of Pathology, 1947, Vol. 23, pp. 695- 720, the disclosure of which is incorporated by reference. The plot of 49.44 degrees Celsius at 1 ^O seconds is just under the dashed curve representing "the first
morphological evidence of thermal damage," such as slight reddening. At the set temperature, the curve indicates that the first reversible damage occurs at 195 seconds. Thus, according to Moritz and Henriques, the set temperature and treatment time are safe, and at worse might produce slight reddening of the treatment area.
[0052] Based on the data of Moritz and Henriques cited above, Xu and Qian in an article entitled "Analysis of Thermal Injury Process Based on Enzyme Deactivation Mechanisms," in Journal of Biomechanical Engineering, Transactions of the ASME, Vol. 117, pp. 462-465 (1995), the disclosure of which is incorporated by reference, developed an equation for a damage function, 6, based on enzyme deactivation concepts.
, _ }• lMCTOφflOOz)
Ωiτ ! +8*104 exp(-195^) where z = 1 -305.65/T 0K, and t is in seconds
In this model T=322.59 CK and is constant, therefore,
Ω-4.947*l(T3*Δt=0.742 for 150 seconds.
Example 1
Temperature dependent death curves for P. acnes.
[0053] While the bacteria P. acnes is not normally present in the nail bed, nor the cause of onychomycosis, the reaction of P. acnes to heating can be considered illustrative of the expected reactions of those infection agents which are responsible for onychomycosis and other nail bed infections treatable by the device described herein.
[0054] Materials and Methods: The bacterial strain P. acnes was purchased from The American Type Culture Collection ATCC (No. 11827, Lot 419571, Manassas, VA). The cultures were stored in KWIK-STIK lyophilized preparations. The lyophilized cells (P. acnes) were rehydrated according to the manufacturers recommendations and initially grown on a streak plate to isolate individual colonies under anaerobic conditions. These plates were then incubated overnight at 37 degrees Celsius in an anaerobic chamber. Individual colonies were then isolated and inoculated into TSB-growth media with medium agitation overnight. From these aliquots of 0.1 ml of TSB broth culture was arfrlerl to the 0.9 ml of PBS sterile buffer. This mixture was then transferred to thin-
walled Eppendorf 1.5 ml tubes and placed in a heating block at various times and temperatures. The cultures after specific incubation times were removed and 0.1 ml of the material was plated onto TSA plates. This mixture was then spread with a sterile hockey-stick and then allowed to incubate at 37 degrees Celsius for 5 days in anaerobic conditions. The plates were then removed and colonies were counted and recorded. The results are demonstrated in FIGURE 10. FIGURE 10 demonstrates the rapid decline of P. acnes in response to various temperatures and duration of treatment. The baseline P. acnes colony count that had not been exposed to the heat source was 1050.
[0055] Results: A general trend of reduction of required time to kill the bacterial strain is seen at higher temperature incubations. Also of note is the temporal thermal threshold where the number of colonies drops off in a very steep fashion. By using the curves generated by such experiments the optimal thermal output and the timing for each temperature can be extrapolated for a localized heating device. The in vitro data shown demonstrates significant sensitivity of P. acnes bacterial cells to the effects of sustained low-level heat. Temperatures of 55 degrees Celsius result in the death of substantially all of the bacteria after ZVz minutes. Temperatures of 58 and 59 degrees Celsius result in the death of substantially all of the bacteria after 2 minutes. These curves demonstrate that P, acnes can be rendered largely non-viable by treatment under the conditions shown by the death curves.
Example 2
[0056] Again, though acne is a skin condition, the treatment of skin lesions using heat is considered to be illustrative of utility of heat treatment for onychomycosis and other nail bed infections using the concepts described herein.
[0057] Treatment of acne lesions in human subjects. The inventors have performed preliminary studies on over 100 volunteers experiencing outbreaks of acne lesions. All subjects reported being satisfied with the results obtained. The results showed a clear response to treatment in approximately 90% of subjects treated. No subject reported any serious adverse effects due to treatment. Furthermore, we have discovered that a treated lesion heals more than 80% faster than untreated lesions.
10058J The electrical device used in the present study had an interface of approximately 0.4 cm2. The interface of the device was heated to a constant temperature of approximately 48-50 degrees Celsius prior to application of the device to the skin surface, and the temperature was maintained during the treatment period. Each of the subjects was given instructions on how to use the device and was monitored during the treatment. The treatment consisted of a 2 H minute application of the device to the lesion site. The study called for the application of two treatment cycles to each patient, with the second treatment cycle being administered 12 hours after the first. In practice, however, the treatments were frequently only conducted once on each subject because twelve hours after the first treatment many of the lesions had healed to an extent that they did not require any further treatment,
[0059] Results of experiments performed on volunteer subjects are listed in Table 1. Members of the control group were not treated. Members of the treatment group were treated as described above. Both groups either examined or self-reported the results of treatment over the following 14 days. Only results from study participants who reported data for 14 days were included in the table. The data is reported in terms of the size of the lesion prior to treatment. A lesion size of 100% indicates that the lesion size was unchanged. Lesion size was approximated in increments of 10%. A lesion size of 0% indicates that the lesion had fully healed.
Example 3
[0060] The inventors have tested prototype devices on multiple oral herpes lesions of human volunteers, and the results have shown a complete termination of the herpetic lesion after two applications of the device at 2 1/2 minutes per treatment, 12 hours apart, as described in Example 2. The volunteers reported a marked decrease in healing time after treatment versus the usual healing cycle for lesions of this type.
[0061] AU of the compositions and methods disclosed and claimed herein can be made and executed without undue experimentation in light of the present disclosure- While the compositions and methods of this invention have been described in terms of preferred embodiments, it will be apparent to those of skill in the art that variations can be applied to the devices or methods and in the steps or in the sequence of steps of the methods described herein without departing from the concept, spirit and scope of the invention. More specifically, it will be apparent that certain mechanical elements related to those described above can be substituted for the mechanical elements described herein to achieve the same or similar results. AU such similar substitutes and modifications apparent to those skilled in the art are deemed to be within the spirit, scope and concept of the invention as defined by the appended claim.
[0062] Although the present invention and its advantages have been described in detail, it should be understood that various changes, substitutions and alterations can be made herein without departing from the spirit and scope of the invention as defined by the appended claims. Moreover, the scope of the present application is not intended to be limited to the particular embodiments of the process, machine, manufacture, composition of matter, means, methods and steps described in the specification. As one of ordinary skill in the art will readily appreciate from the disclosure of the present invention, processes, machines, manufacture, compositions of matter, means, methods, or steps, presently existing or later to be developed that perform
substantially the same function or achieve substantially the same result as the corresponding embodiments described herein may be utilized according to the present invention. Accordingly, the appended claims are intended to include within their scope such processes, machines, manufacture, compositions of matter, means, methods, or steps.
Claims
1. A device for the heat treatment of nails comprising: at least one thermal delivery surface adapted to be placed in contact with the nail plate; and a heating element operable to heat the thermal delivery surface to a treatment temperature.
2. The device in claim 1, where in the treatment temperature is within a temperature range selected for combating the fungus, bacteria, or viruses known to contribute to nail bed infections.
3. The device in claim 1 , wherein the treatment temperature is in a range of about 45 degrees Celsius to about 65 degrees Celsius.
4. The device in claim 1 , wherein the nail bed infection is a fungal infection.
5. The device in claim 1, wherein the nail bed infection is a dermatophyte infection.
6. The device in claim 1 , wherein the nail bed infection is a bacterial infection.
7. The device in claim 1, wherein the nail bed infection is a viral infection.
8. The device in claim 1, wherein the nail bed infection is a mold infection.
9. The device in claim 1, wherein the nail bed infection is a non- dermatophyte yeast infection.
10. The device in claim 1 , further comprising a spring wherein the spring is operable to apply a downward pressure on the thermal delivery surface.
11. The device in claim 1 , wherein the thermal delivery surfaces is integrated in one or more flexible straps.
12. The device in claim 11 , wherein the flexible strap is held in place by an adhesive fastening system.
13. The device in claim 11 , wherein the flexible strap is held in place by a mechanical fastening system.
14. The device of claim 1 further comprising: a temperature sensor; and a controller electrically connected to the heating element and the temperature sensor, wherein the controller is operable to control the heating element in response to a signal from the temperature sensor and regulate the temperature of the thermal delivery surface to the treatment temperature.
15. The device in claim 10, wherein the controller comprises a microprocessor.
16. The device in claim 10, wherein the controller comprises a timer.
17. The device in claim 12, wherein the timer operates between 10 seconds and 30 minutes.
18. The device in claim 10, wherein the controller includes a PID algorithm for temperature control.
19. The device in claim 10, wherein the controller comprises a separate housing and is connected to the thermal delivery surface by wire leads.
20. The device in claim 18 wherein the separate housing comprises a user interface.
21. The device in claim 1 , further comprising a thermal transfer medium to aid the transfer of heat from the thermal delivery surface to the nail plate.
22. The device in claim 21 , wherein the thermal transfer medium is adapted to fit over the nail plate.
23. The device in claim 22, wherein the thermal transfer medium further comprises a deformable thermally conductive material, the deformable material able to deform when placed in contact with the patent's nail plate to provided improved transfer of thermal energy from the thermal delivery surface to the nail plate.
24. The device in claim 21 , further comprising a thermal gel, the thermal gel able to fill the air gap formed between the nail plate and the nail bed to provide improved transfer of thermal energy from the thermal delivery surface to the nail plate.
25. The device in claim 24 wherein the thermal gel further comprises an antifungal agent.
26. A method of treating or preventing nail bed infection by application of heat, the method comprising: applying a thermal delivery surface to the nail plate; heating the thermal delivery surface to transfer heat to a nail bed infection at a temperature selected for treatment of a the nail bed infection; and raising the temperature of the nail plate to the temperature for a predetermined period of time to provide the treatment to the nail bed infection.
27. The method recited in claim 26, wherein the nail bed infection is a fungal infection.
28. The method recited in claim 26, wherein the nail bed infection is a dermatophyte infection.
29. The method recited in claim 26, wherein the nail bed infection is a bacterial infection.
30. The method recited in claim 26, wherein the nail bed infection is a viral infection.
31. The method recited in claim 26, wherein the nail bed infection is a mold infection.
32. The method recited in claim 26, wherein the nail bed infection is a non- dermatophyte yeast infection.
33. The method of claim 26, where in the treatment temperature is within a temperature range capable of combating the fungus, bacteria, or viruses known to contribute to nail bed infections.
34. The method of claim 26, wherein the temperature is a temperature between about 46 degrees Celsius and about 65 degrees Celsius.
35. The method of claim 26, further comprising applying a thermal transfer medium to the nail plate to aid in the transfer of thermal energy from the thermal delivery surface.
36. The method of claim 35, further comprising applying a thermal gel between the nail bed and nail plate.
37. The method of claim 35, wherein the thermal gel further comprises an anti-fungal agent.
38. The method of claim 26, further comprising indicating operation information visually and aurally.
39. A method of treating or preventing nail bed infection by application of heat, the method comprising: selecting the size and shape of a thermal delivery surface to correspond to the size and shape of the nail to be treated; applying the thermal delivery surface to the nail plate; removably connecting a heating element to a controller; heating the thermal delivery surface to transfer heat to a nail bed infection at a temperature selected for treatment of a the nail bed infection; and raising the temperature of the nail plate to the temperature for a predetermined period of time to provide the treatment to the nail bed infection.
40. The method of Claim 39, where in the treatment temperature is within a temperature range selected for combating the fungus, bacteria, or viruses known to contribute to nail bed infections.
41. The method of Claim 39, wherein the treatment temperature is in a range of about 45 degrees Celsius to about 65 degrees Celsius.
42. The method of Claim 39, wherein the nail bed infection is a fungal infection.
43. The method of Claim 39, wherein the nail bed infection is a dermatophyte infection.
44. The method of Claim 39, wherein the nail bed infection is a bacterial infection.
45. The method of Claim 39, wherein the nail bed infection is a viral infection.
46. The device in claim 1 , wherein the nail bed infection is a mold infection.
47. The device in claim 1, wherein the nail bed infection is a non- dermatophyte yeast infection.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08827360A EP2187848A4 (en) | 2007-08-15 | 2008-08-15 | Treatment of nail-bed fungus by application of heat |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/839,167 | 2007-08-15 | ||
US11/839,167 US20090048590A1 (en) | 2007-08-15 | 2007-08-15 | Systems and methods for treating nail-bed fungus through application of heat |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009023812A1 true WO2009023812A1 (en) | 2009-02-19 |
Family
ID=40351171
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2008/073258 WO2009023812A1 (en) | 2007-08-15 | 2008-08-15 | Treatment of nail-bed fungus by application of heat |
Country Status (3)
Country | Link |
---|---|
US (1) | US20090048590A1 (en) |
EP (1) | EP2187848A4 (en) |
WO (1) | WO2009023812A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102016012481A1 (en) * | 2016-10-18 | 2018-05-03 | Tietze Chemical Consulting UG (haftungsbeschränkt) | Thermal treatment of nail fungus diseases |
EP3544667A4 (en) * | 2016-11-28 | 2020-12-02 | Therma Bright Inc. | Devices for applying a topical treatment |
US11737915B2 (en) | 2021-03-02 | 2023-08-29 | Ebelechukwu Nsofor | Fungal infection treatment |
US11992640B2 (en) | 2016-11-28 | 2024-05-28 | The Jenex Corporation | Devices for applying a topical treatment |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110015549A1 (en) * | 2005-01-13 | 2011-01-20 | Shimon Eckhouse | Method and apparatus for treating a diseased nail |
US7793666B2 (en) * | 2005-07-28 | 2010-09-14 | Innovation Biomedical Devices, Inc. | Apparatus and method for treatment of infected nail |
US20100021530A1 (en) * | 2008-07-25 | 2010-01-28 | Innovation Biomedical Devices, Inc. | Enhanced trans-keratin drug delivery |
WO2012011098A1 (en) * | 2010-07-19 | 2012-01-26 | Ultrashape Ltd. | Methods and systems for treating onychomycosis using focused ultraound |
US9072577B1 (en) * | 2010-11-29 | 2015-07-07 | Joseph G. Ferko, III | Portable medical cooling assembly |
US11285040B2 (en) | 2012-01-04 | 2022-03-29 | Sight Sciences, Inc. | Combination treatment systems |
US10973680B2 (en) | 2012-01-04 | 2021-04-13 | Sight Sciences, Inc. | Controller for dry eye treatment systems |
US9724230B2 (en) | 2012-01-04 | 2017-08-08 | Sight Sciences, Inc. | Dry eye treatment apparatus and methods |
US9510972B2 (en) * | 2012-01-04 | 2016-12-06 | Sight Sciences, Inc. | Dry eye treatment systems |
NZ731143A (en) | 2014-10-21 | 2021-07-30 | Hexima Ltd | A method of treatment |
CN107158505B (en) * | 2017-05-27 | 2020-03-17 | 吉林大学 | Infusion chair with heat preservation function |
FR3117010B1 (en) * | 2020-12-03 | 2024-01-12 | Eurofeedback Sa | System and method for nail treatment |
FR3136154A1 (en) * | 2023-06-05 | 2023-12-08 | Eurofeedback | System and method for nail treatment |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5916545A (en) * | 1993-07-28 | 1999-06-29 | Pfizer Inc. | Antifungal nail solution |
US6090788A (en) * | 1997-07-28 | 2000-07-18 | Dermatolazer Technologies Ltd. | Phototherapy based method for treating pathogens and composition for effecting same |
US20040249426A1 (en) * | 2003-05-16 | 2004-12-09 | Hoenig Peter A. | Apparatus and method for the treatment of infectious disease in keratinized tissue |
US6960201B2 (en) * | 2002-02-11 | 2005-11-01 | Quanticum, Llc | Method for the prevention and treatment of skin and nail infections |
US20060212098A1 (en) * | 2005-01-13 | 2006-09-21 | Constantinos Demetriou | Method and apparatus for treating a diseased nail |
US7137979B2 (en) * | 2003-05-31 | 2006-11-21 | Tyrell, Inc. | Methods and devices for the treatment of skin lesions |
US20070027481A1 (en) * | 2005-07-28 | 2007-02-01 | Weinfield Todd A | Apparatus and Method for Treatment of Infected Nail |
US20070104664A1 (en) * | 2005-10-26 | 2007-05-10 | California Institute Of Technology | Treatment of toenail fungus |
US20080076958A1 (en) * | 2006-09-21 | 2008-03-27 | Alma Lasers Ltd. | Method And Apparatus For Treating A Fungal Nail Infection With Shortwave And/Or Microwave Radiation |
US20080139974A1 (en) * | 2006-12-04 | 2008-06-12 | Da Silva Luiz B | Devices and Methods for Treatment of Skin Conditions |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1771076A (en) * | 1929-07-08 | 1930-07-22 | Ultra Violet Generator Corp | Orificial therapeutic device |
US1817823A (en) * | 1930-02-07 | 1931-08-04 | Ito Kinitsu | Medical moxa heater |
US2533955A (en) * | 1948-10-22 | 1950-12-12 | Norman H Pitts | Portable therapeutic device |
US3938526A (en) * | 1974-05-20 | 1976-02-17 | Anderson Weston A | Electrical acupuncture needle heater |
US4106478A (en) * | 1975-06-09 | 1978-08-15 | Sunao Higashijima | Packaged heat generator |
US4381009A (en) * | 1980-01-28 | 1983-04-26 | Bon F Del | Hand-held device for the local heat-treatment of the skin |
US4658823A (en) * | 1986-04-15 | 1987-04-21 | Beddoe Alexander F | Incandescent lamp structure for applying therapeutic heat |
US5074305A (en) * | 1987-07-14 | 1991-12-24 | Venomex, Incorporated | Method for treatment of toxins received from snake bites and the like |
US4873609A (en) * | 1988-06-20 | 1989-10-10 | Mackey Clifford R | Portable electronic unit for treatment of bites by poisonous snakes or other animals or allergic contracts |
US5235990A (en) * | 1991-06-28 | 1993-08-17 | Dempsey Robert N | Apparatus for neutralizing irritants introduced into a body via a bite or sting |
US5445146A (en) * | 1995-03-31 | 1995-08-29 | Bellinger; Gary J. | Biological tissue stimulation by low level optical energy |
US5531775A (en) * | 1991-07-19 | 1996-07-02 | Kabushiki Kaisya Advance | Skin attachment type electric thermal treatment device |
DK168420B1 (en) * | 1992-03-27 | 1994-03-28 | Coloplast As | A heat dressing |
US5421816A (en) * | 1992-10-14 | 1995-06-06 | Endodermic Medical Technologies Company | Ultrasonic transdermal drug delivery system |
US5496356A (en) * | 1993-03-29 | 1996-03-05 | Hudz; Paul H. | Piezo de-toxifier |
US5445608A (en) * | 1993-08-16 | 1995-08-29 | James C. Chen | Method and apparatus for providing light-activated therapy |
US20050288748A1 (en) * | 1993-10-04 | 2005-12-29 | Huan-Chen Li | Medical device for treating skin problems |
US5849029A (en) * | 1995-12-26 | 1998-12-15 | Esc Medical Systems, Ltd. | Method for controlling the thermal profile of the skin |
IT1281688B1 (en) * | 1996-01-19 | 1998-02-26 | Tecnica S R L | PORTABLE TOOL TO TREAT INSECT BITS |
US5792211A (en) * | 1996-05-01 | 1998-08-11 | Teague; Thomas Wade | Method for localized neutralization of poison |
US5830211A (en) * | 1997-03-10 | 1998-11-03 | Santana; Jose A. | Probe to treat viral lesions |
US5817139A (en) * | 1997-05-22 | 1998-10-06 | Polytronics, Ltd. | Skin-contact type antiallergic skin-therapeutic apparatus using voltage pulse train |
US6176857B1 (en) * | 1997-10-22 | 2001-01-23 | Oratec Interventions, Inc. | Method and apparatus for applying thermal energy to tissue asymmetrically |
US6398753B2 (en) * | 1998-04-03 | 2002-06-04 | Mcdaniel David H. | Ultrasound enhancement of percutaneous drug absorption |
US7004933B2 (en) * | 1998-05-29 | 2006-02-28 | Light Bioscience L.L.C. | Ultrasound enhancement of percutaneous drug absorption |
NZ542400A (en) * | 1999-10-08 | 2007-05-31 | Britesmile Professional Inc | Apparatus for simultaneous illumination of teeth |
US20010046654A1 (en) * | 2000-03-27 | 2001-11-29 | Zavitsanos Peter D. | System and method for whitening teeth |
US6471716B1 (en) * | 2000-07-11 | 2002-10-29 | Joseph P. Pecukonis | Low level light therapy method and apparatus with improved wavelength, temperature and voltage control |
US7494502B2 (en) * | 2002-02-11 | 2009-02-24 | Keraderm, Llc | Alteration of the skin and nail for the prevention and treatment of skin and nail infections |
US8404751B2 (en) * | 2002-09-27 | 2013-03-26 | Hallux, Inc. | Subunguicide, and method for treating onychomycosis |
WO2005110272A1 (en) * | 2004-05-13 | 2005-11-24 | Waverx, Inc. | Apparatus and method for the treatment of infectious disease in keratinized tissue |
US20060241549A1 (en) * | 2005-04-20 | 2006-10-26 | Sunnen Gerard V | Apparatus and method for precise ozone/oxygen delivery applied to the treatment of dermatological conditions, including gas gangrene, and related disorders |
RU2007146978A (en) * | 2005-05-18 | 2009-06-27 | Тирелл, Инк. (Us) | THERAPEUTIC DEVICE AND METHOD FOR TREATING SKIN DISEASES UNDER THE INFLUENCE OF HEAT |
WO2008035325A1 (en) * | 2006-09-20 | 2008-03-27 | Alma Lasers Ltd | Method and apparatus for treating a fungal nail infection with shortwave and/or microwave radiation |
US20090143842A1 (en) * | 2007-11-02 | 2009-06-04 | Cumbie William E | Phototherapy Treatment and Device for Infections, Diseases, and Disorders |
US20100021530A1 (en) * | 2008-07-25 | 2010-01-28 | Innovation Biomedical Devices, Inc. | Enhanced trans-keratin drug delivery |
US20100100160A1 (en) * | 2008-10-16 | 2010-04-22 | Philometron, Inc. | Methods and devices for self adjusting phototherapeutic intervention |
-
2007
- 2007-08-15 US US11/839,167 patent/US20090048590A1/en not_active Abandoned
-
2008
- 2008-08-15 WO PCT/US2008/073258 patent/WO2009023812A1/en active Application Filing
- 2008-08-15 EP EP08827360A patent/EP2187848A4/en not_active Withdrawn
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5916545A (en) * | 1993-07-28 | 1999-06-29 | Pfizer Inc. | Antifungal nail solution |
US6090788A (en) * | 1997-07-28 | 2000-07-18 | Dermatolazer Technologies Ltd. | Phototherapy based method for treating pathogens and composition for effecting same |
US6960201B2 (en) * | 2002-02-11 | 2005-11-01 | Quanticum, Llc | Method for the prevention and treatment of skin and nail infections |
US20040249426A1 (en) * | 2003-05-16 | 2004-12-09 | Hoenig Peter A. | Apparatus and method for the treatment of infectious disease in keratinized tissue |
US7137979B2 (en) * | 2003-05-31 | 2006-11-21 | Tyrell, Inc. | Methods and devices for the treatment of skin lesions |
US20060212098A1 (en) * | 2005-01-13 | 2006-09-21 | Constantinos Demetriou | Method and apparatus for treating a diseased nail |
US20070027481A1 (en) * | 2005-07-28 | 2007-02-01 | Weinfield Todd A | Apparatus and Method for Treatment of Infected Nail |
US20070104664A1 (en) * | 2005-10-26 | 2007-05-10 | California Institute Of Technology | Treatment of toenail fungus |
US20080076958A1 (en) * | 2006-09-21 | 2008-03-27 | Alma Lasers Ltd. | Method And Apparatus For Treating A Fungal Nail Infection With Shortwave And/Or Microwave Radiation |
US20080139974A1 (en) * | 2006-12-04 | 2008-06-12 | Da Silva Luiz B | Devices and Methods for Treatment of Skin Conditions |
Non-Patent Citations (1)
Title |
---|
See also references of EP2187848A4 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102016012481A1 (en) * | 2016-10-18 | 2018-05-03 | Tietze Chemical Consulting UG (haftungsbeschränkt) | Thermal treatment of nail fungus diseases |
EP3544667A4 (en) * | 2016-11-28 | 2020-12-02 | Therma Bright Inc. | Devices for applying a topical treatment |
US11344707B2 (en) | 2016-11-28 | 2022-05-31 | Therma Bright Inc. | Devices for applying a topical treatment |
US11992640B2 (en) | 2016-11-28 | 2024-05-28 | The Jenex Corporation | Devices for applying a topical treatment |
US11737915B2 (en) | 2021-03-02 | 2023-08-29 | Ebelechukwu Nsofor | Fungal infection treatment |
Also Published As
Publication number | Publication date |
---|---|
EP2187848A1 (en) | 2010-05-26 |
EP2187848A4 (en) | 2011-04-20 |
US20090048590A1 (en) | 2009-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2187848A1 (en) | Treatment of nail-bed fungus by application of heat | |
US20070259316A1 (en) | Treatment device and method for treating or preventing periodontal disease through application of heat | |
WO2009009277A1 (en) | Treatment device and method for treating or preventing periodontal disease through application of heat | |
JP2008540050A (en) | Treatment apparatus and method for treating skin lesions by applying heat | |
US7137979B2 (en) | Methods and devices for the treatment of skin lesions | |
US20160100977A1 (en) | Autonomous temperature control of heating devices for medical treatment | |
EP1255519A2 (en) | Multi-purpose drug and heat therapy treatment system | |
US20090227924A1 (en) | Pixilated bandage | |
JP2000225141A (en) | Battery warming type eye mask | |
CN203885697U (en) | Static moxibustion therapy paste capable of preventing scald | |
US20160135254A1 (en) | Heating pad for targeted location | |
CN212973222U (en) | Heating device | |
ZA200509668B (en) | Methods and devices for the treatment of skin lesions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08827360 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008827360 Country of ref document: EP |